Alamar Biosciences (ALMR) Financials: Revenue & Earnings
$2.31B
Market Cap
-53.13
P/E
500.40
Forward P/E
—
Score
ALMR price $33.36 +1.43 +4.48%
| 2025 |
|---|
| 74211000 |
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately…
ALMR fair value Not meaningful. Price $33.36.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | -0.20 | — | 30.22M |
| 2026-08-10 | -0.22 | -0.31 | 29.40M | 25.86M |
| 2026-05-08 | -1.74 | -1.71 | 26.02M | 26.01M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 86.01K | $30.52 | 2.62M |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 70 | $31.07 | 2.17K |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 24.03K | $30.52 | 733.30K |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 19 | $31.07 | 590 |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 20.07K | $30.52 | 612.51K |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 16 | $31.07 | 497 |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 2.31K | $30.52 | 70.59K |
| 2026-10-26 | Qiming Corporate GP VI, Ltd. | Sell | 2 | $31.07 | 62 |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 3.98K | $29.35 | 116.67K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 30.92K | $30.23 | 934.74K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 61.19K | $30.85 | 1.89M |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 1.11K | $29.35 | 32.58K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 8.64K | $30.23 | 261.13K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 17.09K | $30.85 | 527.35K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 928 | $29.35 | 27.24K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 7.21K | $30.23 | 218.11K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 14.28K | $30.85 | 440.45K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 107 | $29.35 | 3.14K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 832 | $30.23 | 25.15K |
| 2026-10-23 | Qiming Corporate GP VI, Ltd. | Sell | 1.65K | $30.85 | 50.78K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 46.29K | $29.00 | 1.34M |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 36.94K | $29.59 | 1.09M |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 3.68K | $30.81 | 113.47K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 12.93K | $29.00 | 375.00K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 10.32K | $29.59 | 305.34K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 1.03K | $30.81 | 31.70K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 10.80K | $29.00 | 313.20K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 8.62K | $29.59 | 255.07K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 859 | $30.81 | 26.47K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 1.25K | $29.00 | 36.13K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 994 | $29.59 | 29.41K |
| 2026-10-22 | Qiming Corporate GP VI, Ltd. | Sell | 99 | $30.81 | 3.05K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 22.02K | $29.01 | 638.80K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 25.18K | $29.75 | 749.02K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 88.43K | $30.79 | 2.72M |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 6.15K | $29.01 | 178.44K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 7.03K | $29.75 | 209.23K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 24.70K | $30.79 | 760.64K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 5.14K | $29.01 | 149.05K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 5.88K | $29.75 | 174.78K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 20.63K | $30.79 | 635.32K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 592 | $29.01 | 17.17K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 677 | $29.75 | 20.14K |
| 2026-10-21 | Qiming Corporate GP VI, Ltd. | Sell | 2.38K | $30.79 | 73.28K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 7.42K | $26.63 | 197.46K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 72.37K | $27.93 | 2.02M |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 12.45K | $28.44 | 353.99K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 2.07K | $26.63 | 55.18K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 20.22K | $27.93 | 564.66K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 3.48K | $28.44 | 98.89K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 1.73K | $26.63 | 46.07K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 16.89K | $27.93 | 471.65K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 2.90K | $28.44 | 82.59K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 200 | $26.63 | 5.33K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 1.95K | $27.93 | 54.38K |
| 2026-10-20 | Qiming Corporate GP VI, Ltd. | Sell | 335 | $28.44 | 9.53K |
| 2026-10-19 | Qiming Corporate GP VI, Ltd. | Sell | 49.04K | $26.34 | 1.29M |
| 2026-10-19 | Qiming Corporate GP VI, Ltd. | Sell | 13.70K | $26.34 | 360.88K |
| 2026-10-19 | Qiming Corporate GP VI, Ltd. | Sell | 11.44K | $26.34 | 301.41K |
| 2026-10-19 | Qiming Corporate GP VI, Ltd. | Sell | 1.32K | $26.34 | 34.77K |
| 2026-10-16 | Qiming Corporate GP VI, Ltd. | Sell | 88 | $27.02 | 2.38K |
| 2026-10-16 | Qiming Corporate GP VI, Ltd. | Sell | 25 | $27.02 | 676 |
| 2026-10-16 | Qiming Corporate GP VI, Ltd. | Sell | 21 | $27.02 | 567 |
| 2026-10-16 | Qiming Corporate GP VI, Ltd. | Sell | 2 | $27.02 | 54 |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 112.39K | $27.73 | 3.12M |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 325 | $28.26 | 9.18K |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 31.40K | $27.73 | 870.64K |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 90 | $28.26 | 2.54K |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 26.22K | $27.73 | 727.19K |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 76 | $28.26 | 2.15K |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 3.02K | $27.73 | 83.86K |
| 2026-10-15 | Qiming Corporate GP VI, Ltd. | Sell | 9 | $28.26 | 254 |
| 2026-09-14 | Brottem John L. | Buy | 85.00K | $27.99 | 2.38M |
| 2026-09-14 | Brottem John L. | Buy | 29.00K | — | — |
| 2026-09-14 | Brottem John L. | Other | 0 | — | — |
| 2026-09-01 | RAGUSA ROBERT P | Buy | 25.60K | $29.36 | 751.59K |
| 2026-09-01 | RAGUSA ROBERT P | Buy | 5.69K | — | — |
| 2026-09-01 | RAGUSA ROBERT P | Other | 0 | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 6.88M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 6.88M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 1.92M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 1.92M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 1.61M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 1.61M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 185.16K | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Buy | 185.16K | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Sell | 4.65M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Sell | 1.92M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Sell | 6.40M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Sell | 5.74M | — | — |
| 2026-04-20 | Qiming Corporate GP VI, Ltd. | Sell | 4.22M | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 346.02K | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 922.15K | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 5.51M | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 4.59M | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 235.29K | $17.00 | 4.00M |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 271.78K | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Sell | 5.51M | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Sell | 3.19M | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | Sell | 2.86M | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 88. Ownership 35.54%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| SANDS CAPITAL ALTERNATIVES, LLC | 4.23M | New | New | 114.62M |
| SAMSARA BIOCAPITAL, LLC | 2.48M | New | New | 67.19M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.20M | New | New | 59.67M |
| ARK INVESTMENT MANAGEMENT LLC | 1.37M | New | New | 37.22M |
| BRAIDWELL LP | 1.08M | New | New | 29.37M |
| ALLIANCEBERNSTEIN L.P. | 1.00M | New | New | 27.17M |
| HHLR ADVISORS, LTD. | 956.46K | New | New | 25.91M |
| BLACKROCK, INC. | 911.45K | New | New | 24.69M |
| MILLENNIUM MANAGEMENT LLC | 865.76K | New | New | 23.45M |
| FMR LLC | 829.42K | New | New | 22.47M |
| PURA VIDA INVESTMENTS, LLC | 755.91K | New | New | 20.48M |
| EMERALD ADVISERS, LLC | 647.18K | New | New | 17.53M |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 613.74K | New | New | 16.63M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 600.00K | New | New | 16.25M |
| VANGUARD CAPITAL MANAGEMENT LLC | 463.38K | New | New | 12.55M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 462.90K | New | New | 12.54M |
| WELLINGTON MANAGEMENT GROUP LLP | 457.97K | New | New | 12.41M |
| EMERALD MUTUAL FUND ADVISERS TRUST | 422.13K | New | New | 11.44M |
| AMERIPRISE FINANCIAL INC | 418.96K | New | New | 11.35M |
| GEODE CAPITAL MANAGEMENT, LLC | 330.13K | New | New | 8.95M |
| WOODLINE PARTNERS LP | 243.32K | New | New | 6.59M |
| NEW YORK STATE COMMON RETIREMENT FUND | 200.76K | New | New | 5.44M |
| CITADEL ADVISORS LLC | 180.00K | New | New | 4.88M |
| LORD, ABBETT & CO. LLC | 177.55K | New | New | 4.81M |
| LMR PARTNERS LLP | 175.00K | New | New | 4.74M |
Alamar Biosciences, Inc. (ALMR) trades at $33.36, with a market cap of $2.31B and a trailing P/E of -53.13. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2025 |
|---|
| 74211000 |
Insights · Dividends · Forecast · Financials · Learn
$2.31B
Market Cap
-53.13
P/E
500.40
Forward P/E
—
Score